I wonder how many people subscribe to Seeking Alpha that

New Post Public Reply Private Reply Replies (5) Message Board
Goosebumps Joja #98504
586
I wonder how many people subscribe to Seeking Alpha that are investors here and other CYDY boards and if they know that these articles are the ammunition to lower our stock price and two days from now there will be a great article written by another publication to rise back up our stock price to about where we were last before the decline. The swings we have are pre-planned and the recovery is also pre-planned… welcome to the US market where all stocks are manipulated at some point and some more than others. Especially UTC stocks are manipulated and it’s a fact of life and is legal for those that do this.

The Reddit fiasco is flushing this out for many with the congressional inquiry but the Congressional people that don’t invest or those that do… don’t want to change the system because their campaign funds are paid by these people in one way or another. Do you not see how all government elected Congressional elected officials and Senators don’t make a lot of money but somehow become millionaires while elected and stay in office? Some are great investors and how they invest is…? The system is broke and the foxes are watching the hen house. Don’t expect any changes. This is life for us all. Which team are you on? The longs or the shorts?

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Monitor Class Action Against Xerox Ahead of Deadline

Updated Category News Views 313

Xerox Holdings Corporation Under Legal Scrutiny Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors of Xerox Holdings Corporation (NASDAQ: XRX) to inform them about an ongoing class action lawsuit. Investors are reminded of an important deadline for those wanting to assume the role of lead plaintiff in this case. The deadline for...

Continue Reading
UBS's Caution on Dr. Reddy's Projections Signals Concerns

Updated Category News Views 155

UBS dropped a Sell rating on Dr. Reddy's Laboratories (NSE: DRRD) back in 2024, tagging the stock with a price target of INR 5,700.00. You could feel the tension shift in trading rooms as their assessment sparked fresh chatter about the firm’s US base business revenue projections that seem downright optimistic. UBS Questions Revenue Estimates: Too High or Just Right?...

Continue Reading
Evaluating Apple's Business Landscape Among Top Tech Firms

Updated Category News Views 115

Assessing Market Position and Performance In the dynamic world of technology hardware, it’s crucial for investors to analyze the competition thoroughly. This article takes a closer look at Apple (NASDAQ: AAPL) and compares its financial metrics and market position against its key competitors in the industry. With this analysis, we aim to provide insights into Apple's...

Continue Reading
Back to School: Parents Prepare for Illness and Solutions

Updated Category News Views 191

Back to School: Parents Brace for Sickness A recent survey shows that as children head back to the classroom, many parents anticipate facing a wave of illnesses at home. Conducted by Boiron, a leader in homeopathic remedies, this nationwide survey reveals parents' concerns about the inevitable germs that come along with the school year. Survey Insights on Parental...

Continue Reading
Scarf Systems Achieves SOC 2 Type 2 Examination Success

Updated Category News Views 72

Scarf Systems, Inc. completed a SOC 2 Type 2 examination back in early 2023, solidifying its place as a frontrunner in data security. This wasn't just some routine check; it was a deep dive into how well Scarf protected customer data and adhered to stringent safety protocols. But here’s the kicker—traders started asking: is this enough to keep investors calm? What’s...

Continue Reading